drugset / Trial / NCT07398261
Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children
RandomizedParallel-groupSingle-blindTreatment
Summary
This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children
Timeline
- Start
- 2023-08-28
- Primary completion
- 2026-09-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | 25 mg | Oral |